1[1]Denton M Todd NJ,Kerr KG,ETAL.Molecular epide miology of stenottophomones maltophilia isoloated from clinicl specimans from patients cystic fibrosis and assoliated enviromantal samples[J].J Clin microbiol,1998,36(7):1953-1958.
2[2]Laning D,Ramoark,Road RR,et al.Molecular epiemiology of X Maltophilin colonization and infection in the hospital environment[J].J Clin Microbiol,1995,33(33):513-518.
4[1]Denton M,Todd NJ, Kerr KG, et al. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients cystic fibrosis and assoliated environmental samples.J Clin Microbiol, 1988,36(7): 1953 ～ 1958.
5[5]Bush K, Jacohy GA, Medeiros AA. A functional classification scheme for β - lactam and its correlation with molecular structure. Antimicrob Agents Chemother, 1995,39:1211.
4Hugh R, Ryschenkow E. Pseudomonas maltophilia, an alcaligenes- like species. J Gen Microbiol, 1961, 26(1):123-132.
5Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Baeteriol, 1993, 43(3) : 606-609.
6Gulmez D, Hascelik G. Stenotrophomonas maltophlia: antimiceobial resistance and molecular typing of an emerging pathogen in a Turkish university hospit. Clin Microbiol Infect, 2005, 11 (11) : 880-886.
7Safdar A, Rolston KV. Stenotrophomonas mahophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis, 2007, 45(12):1602-1609.
8Yemisen M, Mete B, Tunali Y, et al. A meningitis case due to Stenotrophomonas maltophilia and review of the literature. Int J Infect Dis, 2008, 12(6) : 125-127.
9Grare M, Dibama HM, Lafosse S, et al. Cationic compounds with ac- tivity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect, 2010, 16(5) :432-438.
10Senol E. Stenotrophomonas maltophilia : the significance and role as a nosocomial pathogen. J Hosp Infect, 2004, 57(1):1-7.
